RTC-30 |
Catalog No.GC37567 |
RTC-30 es una fenotiazina optimizada con potencia anticancerÍgena. RTC-30 contiene un enlazador hidroxilado (N) que confiere una mayor biodisponibilidad oral.
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 1423077-95-5
Sample solution is provided at 25 µL, 10mM.
RTC-30 is an optimized phenothiazine with anti-cancer potency. RTC-30 contains a hydroxylated linker (N) that confers increased oral bioavailability[1].
RTC-30 (0-40 μM; 48 hours) inhibits H1650 lung adenocarcinoma cell growth with an GI50 of 15 μM[1]. Cell Viability Assay[1] Cell Line: H1650 lung adenocarcinoma cells
[1]. Kastrinsky DB, et al. Reengineered tricyclic anti-cancer agents. Bioorg Med Chem. 2015 Oct 1;23(19):6528-34.
Average Rating: 5
(Based on Reviews and 38 reference(s) in Google Scholar.)GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *